Incidental prostate cancer: is prostate-specific antigen density a valid predictor? A case–control study
PSAD, whether dichotomized (threshold of >0.1 ng/mL/cc) or continuous, didn't predict iPCa in men with large prostates. To optimize cancer detection, patients with large prostates may profit from prostate MRI before bladder outlet surgery, especially those with a history of prior prostate biopsy. Further research, including larger multicenter studies, is needed to validate our results.
Authors
- Florian Wagenlehner (ORCID: https://orcid.org/0000-0002-2909-0797)
- Mahmoud Farzat (ORCID: https://orcid.org/0000-0003-1989-2187)
Institutions
- Justus-Liebig-Universität Gießen (DE)
- University of Siegen (DE)
- Diakonie Klinikum Jung-Stilling (DE)
Publication Details
- Journal
- Therapeutic Advances in Urology
- Published
- 2025-10-01
- DOI
- https://doi.org/10.1177/17562872251386996
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00